InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: Aqua post# 147210

Friday, 03/06/2015 3:14:04 PM

Friday, March 06, 2015 3:14:04 PM

Post# of 399708
Yes Nasrat and JT have surrounded themselves with a management team worthy of the Big Leagues. Nasrat is the single biggest shareholder and nobody wants the launch of Elite's ADT pipeline more than he does.

He's a Big League veteran from Actavis. The man has been straight up with hard questions asked of him during the conference calls. If he tells me personally he can get Elite's ADT pipeline to market and that he has 17 ADT in mind. I believe him.

Excellent choice for a replacement Jerry Treppel- Excellent choice indeed.

"We are pleased with the guidance we have received from the FDA and the clear regulatory pathway forward for ELI-200. Our filing date is expected to be in the third quarter of this year, and we are encouraged that the FDA review leading to approval is expected to be completed by early 2016," said Nasrat Hakim, President and CEO of Elite Pharmaceuticals. "In preparation for the launch of ELI-200, we are also expanding our manufacturing facility and adding capacity. ELI-200 is the first of our abuse-deterrent opioid pipeline of products under development utilizing our proprietary technology platform."

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News